What's trending

5 most popular innovation stories in Houston this week

The Ion has a new partner focused on diversity, events not to miss this month, and more trending Houston innovation news. Photo courtesy of The Ion

Editor's note: March is off to a strong start. Today wraps up Houston Tech Rodeo — a week full of events focused on innovation and entrepreneurship, and SXSW is just around the corner. Trending Houston innovation news included a new partnership for The Ion, events to attend this month, and a couple startup profiles not to miss.

3 Houston innovators to know this week

This week's Houston innovators to know roundup includes Harvin Moore, James Lancaster, and Joshua Baer. Courtesy photos

Today starts the Houston Tech Rodeo — a week full of innovation-focused events — and its sure to corral entrepreneurs and investors across the city spur discussions of innovation and technology.

This week's Houston innovators to know includes the man at the helm of the organization behind the Tech Rodeo, plus two investors that are making moves in Houston as well as statewide.

Click here to continue reading.

10+ can't-miss Houston business and innovation events for March

It's a busy month in Houston. Luis Alvarez/Getty Images

March is a busy month for Houston in general — but especially when it comes to innovation. The inaugural Houston Tech Rodeo starts out the month and the Rice Business Plan Competition closes out March in a few weeks — and the interactive weekend at SXSW falls right in the middle of the month for those planning the trip to Austin.

But for the Houston innovators in the energy industry, March got a little less busy when CERAWeek by IHS Markit was canceled due to the growing threat of the coronavirus, or COVID19.

Click here to continue reading.

Houston entrepreneur designs clothing that benefits skin health

Emeline Kuhner-Stout, founder of Élastique Athletics, wanted to create a product that was easy to wear and benefitted lymphatic health. Photo courtesy of Élastique Athletics

A few years ago, Emeline Kuhner-Stout, a French ex-pat, was figuring out life as a new mom in a new city. She found her new life in Houston to be sedentary and all consumed with taking care of her baby. Her only time for herself were her daily trips to the gym, and she wanted to make it worth her while.

"There were so many more things I wanted to do for myself, and I just didn't have the time," Kuhner-Stout tells InnovationMap. "It would be so much more efficient if there was a way to combine [elements] to make products that would perform for us."

She noticed at this time that people were starting to care about what they wear to the gym, and she was also looking into the causes of cellulite. Kuhner-Stout and her husband, Myron, who's a patent attorney, started doing some research and found that there weren't any products that existed at the confluence of activewear and skincare. Élastique Athletics was born to fill that need.

Click here to continue reading.

The Ion announces partnership with nonprofit to serve Houston's diverse entrepreneurs

The Ion has tapped DivInc. as a partner. Courtesy of The Ion

Houston is ranked the No. 1 diverse city in the nation, and a local organization has forged a new partnership to make sure that diversity is represented within the city's innovation ecosystem.

The Ion, an innovation hub currently rising in Midtown Sears Building, and DivInc, a Texas nonprofit, have agreed to partner to advance diversity among Houston entrepreneurs. It's Austin-based DivInc's first Houston initiative, according to a news release.

Click here to continue reading.

Houston-area construction tech startup prepares for next phase at SXSW

A Houston startup that uses tech to speed up and lower the cost of home building will pitch at SXSW this year. Photo via 3spacemakers.com

Conroe-based construction tech company that specializes in creating technology to develop cost-efficient high-quality homes built in half the time is gearing up for new growth due to their recent selection as a finalist in SXSW Pitch 2020.

3Space Makers was at first selected as an alternate in the "Artificial Intelligence, Robotics & Voice" category for the 12th annual SXSW Pitch, formerly known as SXSW Accelerator, but was recently bumped to finalist.

"It's gratifying to learn that we have been selected," Ted Cox, CEO and co-founder of 3Space Makers, tells InnovationMap. "Our team has been working really hard for this moment. I think that not only do we have a good product, but the mission that we are on is what is resonating the most."

Click here to continue reading.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News